Baraclude and Diovan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Baraclude (entecavir) and Diovan (valsartan). Common drug interactions include herpes zoster among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Baraclude and Diovan. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Baraclude?

Baraclude has active ingredients of entecavir. It is often used in hepatitis b. eHealthMe is studying from 6,175 Baraclude users. Check the latest studies of Baraclude.

What is Diovan?

Diovan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 83,154 Diovan users. Check the latest studies of Diovan.

On Aug, 01, 2026

47 people who take Baraclude and Diovan together, and have interactions are studied.

What are the common drug interactions of Baraclude and Diovan, by gender? *:

female:

Herpes zoster
Altered state of consciousness (altered state of mind)
Erysipelas (bacterial skin infection)
Hyperammonaemia
Hyperglycaemia (high blood sugar)
Lipogranuloma (a foreign body inflammation of adipose tissue containing granulation tissue and oil cysts)
Liver disorder (liver diseases)
Renal failure (kidney dysfunction)
Disease progression
Pancreatitis (inflammation of pancreas)

male:

Diarrhoea
Decreased appetite
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Renal failure acute (rapid kidney dysfunction)
Respiratory failure (inadequate gas exchange by the respiratory system)
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Blast cell count increased
C-reactive protein increased
Cardiac failure
Fatigue (feeling of tiredness)

What are the common drug interactions of Baraclude and Diovan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Diarrhoea
Myopathy (a muscular disease in which the muscle fibres do not function)
Neuromyopathy (disease of both muscles and nerves)
Fatigue (feeling of tiredness)
Gallbladder polyp (growths or lesions resembling growths (polypoid lesions) in the wall of the gallbladder)
Glomerulosclerosis (a hardening of the glomerulus in the kidney)
Hepatic steatosis (fatty liver disease)
Hepatitis b virus test positive
Interstitial lung disease
Nephropathy (damage to or disease of a kidney)

50-59:

Lipogranuloma (a foreign body inflammation of adipose tissue containing granulation tissue and oil cysts)
Alanine aminotransferase increased
Anaemia (lack of blood)
Aneurysm ruptured (expansion of the aneurysm reaches a point where the wall becomes too thin, the aneurysm will rupture)
Ascites (accumulation of fluid in the abdominal cavity)
Aspartate aminotransferase increased
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Blood alkaline phosphatase increased
Duodenal ulcer haemorrhage (bleeding duodenal ulcer)
Faeces discoloured

60+:

Decreased appetite
Pneumonia
Proteinuria (presence of protein in the urine)
Renal failure (kidney dysfunction)
Renal failure acute (rapid kidney dysfunction)
Respiratory failure (inadequate gas exchange by the respiratory system)
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Skin lesion
Skin necrosis (skin damage)
Alanine aminotransferase increased

What are the existing conditions these people have? *

Hepatic Neoplasm Malignant (liver cancer): 16 people, 34.04%
Constipation: 7 people, 14.89%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 6 people, 12.77%
Anaemia (lack of blood): 5 people, 10.64%
Gastric Ulcer (stomach ulcer): 5 people, 10.64%
Itching: 5 people, 10.64%
Stress And Anxiety: 4 people, 8.51%
Sinusitis (inflammation of sinus): 4 people, 8.51%
Diabetes: 4 people, 8.51%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 4 people, 8.51%

* Approximation only. Some reports may have incomplete information.

Do you take Baraclude and Diovan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously